You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Preleukemia

Showing 51 - 75 of 1,392
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Higher Risk Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial (AMG 176, Azacitidine)

Not yet recruiting
  • Higher Risk Myelodysplastic Syndrome
  • Chronic Myelomonocytic Leukemia
  • (no location specified)
Jul 29, 2022

Low Risk MDS Trial (R906289 Monosodium (R289 Na))

Not yet recruiting
  • Low Risk Myelodysplastic Syndromes
  • R906289 Monosodium (R289 Na)
  • (no location specified)
Jul 22, 2022

Acute Myeloid Leukaemia (AML), Myelodysplastic Syndrome (MDS), Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Trial

Not yet recruiting
  • Acute Myeloid Leukaemia (AML)
  • +2 more
  • (no location specified)
Sep 6, 2022

Clonal Cytopenia of Undetermined Significance, MDS Trial in Saint Louis (Atorvastatin, Rosuvastatin)

Not yet recruiting
  • Clonal Cytopenia of Undetermined Significance
  • Myelodysplastic Syndromes
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 28, 2022

Acute Myeloid Leukemia, MDS Trial (Cladribine, Cytarabine, Decitabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Mar 1, 2023

Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

Not yet recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Cytokine Induced Memory-like Natural Killer Cells
  • Interleukin-2
  • Boston, Massachusetts
  • +1 more
Nov 14, 2023

Myelodysplastic Syndrome Trial in Japan (SyB C-1101)

Completed
  • Myelodysplastic Syndrome
  • SyB C-1101
  • Nagoya, Aichi, Japan
  • +8 more
Nov 14, 2022

MDS, Graft Vs Host Disease, Graft-versus-host-disease Trial in Miami (Busulfan, Melphalan, Fludarabine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Miami, Florida
    Miami Cancer Institute
Jan 10, 2023

Acute Myeloid Leukemia, MDS Trial in Omaha (ONC201)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Omaha, Nebraska
    University of Nebraska Medical Center
Aug 4, 2022

MDS, Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial in Pittsburgh (IFN-? (interferon gamma-1b) injection)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • IFN-γ (interferon gamma-1b) injection
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jan 5, 2023

Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial run

Recruiting
  • Severe Aplastic Anemia (SAA)
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 28, 2023

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Houston (DSP107, Azacitidine, Venetoclax)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • DSP107
  • +2 more
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center, Department of
Nov 13, 2022

Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute Trial in Boston (radiation, drug, biological,

Recruiting
  • Stem Cell Transplant Complications
  • +4 more
  • Radiation
  • +7 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 19, 2023

Mean Platelet Volume and Its Relation to Risk Stratification of

Completed
  • Myelodysplastic Syndromes
    • (no location specified)
    Jan 21, 2022

    Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia,

    Recruiting
    • Autoimmune Hemolytic Anemia
    • +5 more
    • cytokine essays
    • +6 more
    • Milano, Italy
      Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico
    Jul 3, 2023

    Relapsed / Refractory MDS Trial (NCR300)

    Not yet recruiting
    • Relapsed / Refractory Myelodysplastic Syndromes
    • (no location specified)
    May 7, 2022

    Leukemia, MDS Trial in Gainesville (Diet)

    Recruiting
    • Leukemia
    • Myelodysplastic Syndromes
    • Diet
    • Gainesville, Florida
      UF Health Cancer Center
    Aug 9, 2022

    Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Hematopoietic Stem Cell Transplant (HSCT) Trial in Pittsburgh

    Active, not recruiting
    • Acute Myeloid Leukemia (AML)
    • +2 more
    • Reduced-Intensity Conditioning Regimen
    • Myeloablative Conditioning Regimen
    • Pittsburgh, Pennsylvania
      UPMC Children's Hospital of Pittsburgh
    Jan 4, 2023

    MDS Trial (AG-946, Placebo)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • (no location specified)
    Aug 4, 2022

    Anemia Trial (Luspatercept)

    Not yet recruiting
    • Anemia
    • Luspatercept
    • (no location specified)
    May 26, 2023

    MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

    Not yet recruiting
    • Myelodysplastic Syndromes
    • +3 more
    • Subcutaneous azacitidine
    • Oral decitabine/cedazuridine
    • Newcastle, New South Wales, Australia
      Calvary Mater Newcastle
    May 29, 2023

    MDS Trial in Saint Louis (vosaroxin, Azacitidine)

    Active, not recruiting
    • Myelodysplastic Syndromes
    • Saint Louis, Missouri
      Washington University School of Medicine
    Mar 23, 2022

    MDS Trial in Houston (Sertraline, Bone Marrow Aspirate/Biopsy)

    Terminated
    • Myelodysplastic Syndromes
    • Houston, Texas
    • +1 more
    May 31, 2022

    Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R Trial in Canada, United States (Etavopivat)

    Recruiting
    • Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R
    • Ocala, Florida
    • +3 more
    Jan 30, 2023

    High Risk Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston

    Completed
    • High Risk Myelodysplastic Syndrome
    • +2 more
    • Daratumumab
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 21, 2022